Therefore, in embryogenesis, ADAR1 is essential to avoid signalling downstream of dsRNA, but in cancer cells the primary aim is to avoid growth arrest, and ISG expression seems to be a ‘side effect’ which, nevertheless, can be exploited for immunotherapy [65,90]. The gene discussed is ADAR; the disease is cancer.